| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.95B | +58.2% |
| R&D Expense | $323.0M | -7.4% |
| SG&A Expense | $455.0M | -61.1% |
| Pre-tax Income | $1.06B | +299.6% |
| Income Tax | -$347.0M | -4437.5% |
| Net Income | $1.41B | +360.8% |
| EPS (Basic) | $1.60 | +362.3% |
| EPS (Diluted) | $1.56 | +355.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.33B | -10.4% |
| Current Assets | $25.10B | -21.0% |
| Total Assets | $26.19B | -19.0% |
| Current Liabilities | $18.10B | -29.1% |
| Total Liabilities | $18.21B | -28.9% |
| Stockholders' Equity | $7.97B | +19.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.0M | -113.3% |
| Investing Cash Flow | -$148.0M | +74.6% |
| Financing Cash Flow | -$345.0M | +43.4% |